Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001493152-24-006615
Filing Date
2024-02-14
Accepted
2024-02-14 16:05:37
Documents
1

Document Format Files

Seq Description Document Type Size
1 formsc13g.htm SC 13G 54701
  Complete submission text file 0001493152-24-006615.txt   56316
Mailing Address 60 EAST 42ND STREET 9TH FLOOR NEW YORK NY 10165
Business Address 60 EAST 42ND STREET 9TH FLOOR NEW YORK NY 10165 212-446-2465
Newtyn Management, LLC (Filed by) CIK: 0001569241 (see all company filings)

EIN.: 453017573 | State of Incorp.: NY | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 99 HAYDEN AVENUE BUILDING B, SUITE 450 LEXINGTON MA 02421
Business Address 99 HAYDEN AVENUE BUILDING B, SUITE 450 LEXINGTON MA 02421 857-285-4140
Cyteir Therapeutics, Inc. (Subject) CIK: 0001662244 (see all company filings)

EIN.: 455429901 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-92616 | Film No.: 24637783
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)